NMPA Approval

Mixed Protamine Human Insulin Injection (30R)

Approval Number

国药准字S20093036

Company复星万邦（江苏）医药集团有限公司

Registration Date

October 22, 2024

Drug Information

Generic Name

30/70混合重组人胰岛素注射液

Trade Name

万邦林

Dosage Form

注射剂

Strength

3ml:300单位

Drug Type

生物制品

Registration Date

October 22, 2024

Company Information

Applicant Company

Company Name复星万邦（江苏）医药集团有限公司

Company Address

江苏省徐州市金山桥开发区综合区洞山南侧

Manufacturing Company

Company Name复星万邦（江苏）医药集团有限公司

Company Address

江苏省徐州市金山桥开发区综合区洞山南侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

30/70混合重组人胰岛素注射液 - NMPA 批准文号 | MedPath